Innovid Q1 revenue $36.7M (+21% YoY), net loss narrows, EBITDA positive; raises FY guidance

Innovid Corp.

2024-Q1 EPS reported -$0.04 revenue$36,738,000

Q1 revenue $36.7M, up 21% YoY; net loss improved to $6.2M from $8.6M.
Adjusted EBITDA $4.4M (12% margin) vs $0.1M; free cash flow $2.0M vs -$2.8M.
FY 2024 revenue guidance raised to $156M-$163M; FY Adj. EBITDA guidance raised to $24M-$29M.
Q2 2024 revenue expected $37.5M-$39.5M (9-14% YoY growth); Adj. EBITDA $5.0M-$6.0M.
New client wins include Eli Lilly, Verizon; launched Harmony Direct supply-path optimization.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Innovid Corp. reported the quarter ended March 31, 2024 results: revenue $36.7 million, net income net loss was $6.2 million.

Period: the quarter ended March 31, 2024
Revenue: $36.7 million
Net income: net loss was $6.2 million
Result: reported results

Exact text from the filing

in such filing. --- EX-99.1 (EX-99.1) --- Innovid Reports Q1 2024 Financial Results • Company exceeds both revenue and Adjusted EBITDA guidance for Q1 • Q1 revenue grew to $36.7 million, up 21% year-over-year • Q1 net loss improved year-over-year to $6.2 million and Adjusted EBITDA* improved to $4.4 million, representing a 12% Adjusted EBITDA margin* • Company

View on SEC.gov

708 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0001835378-24-000052

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.